Clozapine therapy does not produce the rapid response that may be required
in severely disturbed patients. The latter, not uncommonly, obstruct treatm
ent by refusing to give blood for haematological monitoring or refusing to
swallow tablets. Whereas electroconvulsive therapy (ECT) may be used for ra
pid behavioural control, the effects wane once the treatment course comes t
o an end. This paper reports an alternative strategy in such patients - com
bined jointly initiated therapy with clozapine and ECT. Six disturbed patie
nts with treatment resistant schizophrenia were given a course of 12 ECT ov
er 6 weeks. Blood was drawn for clozapine monitoring during the first anaes
thetic, allowing the introduction of clozapine on day 6. There was a mean 3
2% improvement in Brief Psychiatric Rating Scale scores at week 6. This imp
rovement persisted after the cessation of ECT, by which time all patients w
ere compliant with blood testing and tablet taking. There were no adverse r
eactions apparent in the combination of the two therapies. Elective combine
d ECT and clozapine therapy may be useful in treatment-resistant schizophre
nics where the clinical state necessitates a rapid therapeutic response and
where blood tests are refused. A possible synergistic reaction between clo
zapine and ECT is Worthy of further investigation. mt Clin Psychopharmacol
14:69-72 (C) 1999 Lippincott Williams & Wilkins.